Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vanwalleghem

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 5, 1998
Benefits and concerns of treating pre-dialysis and renal transplant patients with recombinant human erythropoietinY Vanrenterghem, J Vanwalleghem
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 13, 1999
IgA antiglomerular basement membrane disease associated with bronchial carcinoma and monoclonal gammopathyB Maes, J Vanwalleghem, D Kuypers, et al.
Transplantation|December 10, 1999
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporineB D Maes, J Vanwalleghem, D Kuypers, et al.
Transplantation|January 12, 1999
Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for TransplantationL Roels, W Coosemans, J Donck, et al.
Nephron. Clinical Practice|April 6, 2005
Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonateA J Hutchison, B Maes, J Vanwalleghem, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 5, 1998
Benefits and concerns of treating pre-dialysis and renal transplant patients with recombinant human erythropoietinY Vanrenterghem, J Vanwalleghem
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 13, 1999
IgA antiglomerular basement membrane disease associated with bronchial carcinoma and monoclonal gammopathyB Maes, J Vanwalleghem, D Kuypers, et al.
Transplantation|December 10, 1999
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporineB D Maes, J Vanwalleghem, D Kuypers, et al.
Transplantation|January 12, 1999
Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for TransplantationL Roels, W Coosemans, J Donck, et al.
Nephron. Clinical Practice|April 6, 2005
Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonateA J Hutchison, B Maes, J Vanwalleghem, et al.
Pageof 1